Ultrasonic markers of fetal chromosomal abnormalities

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 85, Issue 1, 1999, Pages 105-108

  Kurjak, Asim ^a   Kos, Milan ^a   Stipoljev, Feodora ^a   Latin, Višnja ^a   Funduk Kurjak, Biserka ^a   Kos, Marina ^a   Miškovic, Berivoj ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Chromosomal abnormalities; Screening; Ultrasonography

Indexed keywords

ADULT; CHROMOSOME ABERRATION; CLINICAL TRIAL; CONFERENCE PAPER; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; CYSTIC LYMPHANGIOMA; EDWARDS SYNDROME; FEMALE; FETUS; HUMAN; HYDRAMNIOS; INTRAUTERINE GROWTH RETARDATION; KARYOTYPING; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; TRISOMY 13; TRISOMY 21; TURNER SYNDROME; ULTRASOUND;

EID: 0033026594     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00292-9     Document Type: Conference Paper

References (15)

1. Snijders RJM, Farrias M, Kaisenberg C, Nicolaides KH. Fetal abnormalities. In: Snijders RJM, Nicolaides KH, editors. Ultrasound Markers for Fetal Chromosomal Defects. New York: Parthenon, 1996:1-63.
2. Snijders RJM, Sebire NJ, Nicolaides KH. Assessment of risks. In: Snijders RJM, Nicolaides KH, editors. Ultrasound Markers for Fetal Chromosomal Defects. New York: Parthenon, 1996:80-83.
3. Gonen R., Dar H., Degani S. The karyotype of fetuses with anomalies detected by second trimester ultrasonography. European Journal of Obstetrics. Gynecol Reprod Biol. 58:1995;153-155.
4. Nicolaides K., Shawa L., Brizot M., Snijders R. Ultrasonographically detectable markers of fetal chromosomal defects. Ultrasound Obstet Gynecol. 3:1993;56-69.
5. Kurjak A., Zmijanac J., Relja Z., Rajhvajn B., Klobucar A., Salihagic A. Cordocentesis in the assessment of high risk pregnancies. Int J Feto-Matern Med. 5:1992;73-76.
6. D'Ottavio G., Meir Y.J., Rustico M.A., Pecile V.et al. Screening for fetal anomalies by ultrasound at 14 and 21 weeks. Ultrasound Obstet Gynecol. 10:1997;375-380.
7. Rizzo N., Pitalis M.C., Orsini L.F.et al. Prenatal karyotyping in malformed fetuses. Prenat Diagn. 10:1990;17-23.
8. Nicolaides K.H., Snijders R.J.M., Gosden C.M.et al. Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet. 340:1992;704-707.
9. Halliday J., Lumley J., Bankier A. Karyotype abnormalities in fetuses diagnosed as abnormal on ultrasound before 20 weeks gestational age. Prenat Diagn. 14:1994;689-697.
10. Economides D.L., Whitlow B.J., Kadir R.et al. First trimester sonographic detection of chromosomal abnormalities in an unselected population. Br J Obstet Gynecol. 105:1998;58-62.
11. Guargaglia L., Rosati P. Echographic markers of fetal chromosomopathies. Diagnostic possibilities with transvaginal ultrasonography and our experience. Minerva Ginecol. 49:1997;531-534.
12. Kornman L.H., Morssink L.P., Beekhuis J.R., De Wolf B.T.et al. Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice. Prenat Diagn. 16:1996;797-805.
13. Seeds J.W. Ultrasonographic screening for fetal aneuploidy. New Engl J Med. 337:1997;1689-1690.
14. Bernaschek G., Kolankaya K., Stuempflen I., Deutinger J. Chromosomal abnormalities: how much can we predict by ultrasound examination in low-risk pregnancies? Am J Perinatol. 13:1996;159-163.
15. Drugan A., Johnson M.P., Reicher A., Hume R.F., Itskovicz-Eldor J., Evans M. Second trimester minor ultrasound anomalies: impact on the risk of aneuploidy associated with advanced maternal age. Obstet Gynecol. 88:1996;203-206.